30 results  1 of 2 

1 Comparative Study of Ex Vivo Antiplatelet Activity of Aspirin and Cilostazol in Patients with Diabetes and High Risk of Cardiovascular Disease
Sangmo Hong, Woo Je Lee, Cheol-Young Park
Endocrinol Metab.2022;37(2):233-242.   Published online 2022 April 6     DOI: http://dx.doi.org/10.3803/EnM.2021.1353
      
2 Treatment of In-Stent Stenosis Following Flow Diversion of Intracranial Aneurysms with Cilostazol and Clopidogrel
Ehsan Dowlati, Kory B. Dylan Pasko, Jiaqi Liu, Charles A. Miller, Daniel R. Felbaum, Samir Sur, Jason J. Chang, Ai-Hsi Liu, Rocco A. Armonda, Jeffrey C. Mai
Neurointervention.2021;16(3):285-292.   Published online 2021 September 10     DOI: http://dx.doi.org/10.5469/neuroint.2021.00290
      
3 Cilostazol ameliorates diabetic nephropathy by inhibiting high-glucose-induced apoptosis
Chien-Wen Chian, Yung-Shu Lee, Yi-Ju Lee, Ya-Hui Chen, Chi-Ping Wang, Wen-Chin Lee, Huei-Jane Lee
Korean J Physiol Pharmacol.2020;24(5):403-412.   Published online 2020 September 1     DOI: http://dx.doi.org/10.4196/kjpp.2020.24.5.403
      
4 Combination therapy with cilostazol, aripiprazole, and donepezil protects neuronal cells from β-amyloid neurotoxicity through synergistically enhanced SIRT1 expression
Hye Jin Heo, So Youn Park, Yi Sle Lee, Hwa Kyoung Shin, Ki Whan Hong, Chi Dae Kim
Korean J Physiol Pharmacol.2020;24(4):299-310.   Published online 2020 July 1     DOI: http://dx.doi.org/10.4196/kjpp.2020.24.4.299
      
5 A Comparison Study of Cilostazol and Aspirin on Changes in Volume of Cerebral Small Vessel Disease White Matter Changes: Protocol of a Multicenter, Randomized Controlled Trial
Hyun Jeong Han, Byeong C. Kim, Young Chul Youn, Jee Hyang Jeong, Jong Hun Kim, Jae-Hong Lee, Kee Hyung Park, Kyung Won Park, Eun-Joo Kim, Mi Sun Oh, Yong S. Shim, Hyun Young Park, Bora Yoon, Soo Jin Yoon, Soo-Jin Cho, Key Chung Park, Duk L. Na, Sun Ah Park, Jong-Min Lee, Seong Hye Choi
Dement Neurocogn Disord.2019;18(4):138-148.   Published online 2019 December 13     DOI: http://dx.doi.org/10.12779/dnd.2019.18.4.138
      
6 Population pharmacodynamics of cilostazol in healthy Korean subjects
Yun Seob Jung, Dongwoo Chae, Kyungsoo Park
Transl Clin Pharmacol.2018;26(2):93-98.   Published online 2018 June 18     DOI: http://dx.doi.org/10.12793/tcp.2018.26.2.93
      
7 Cilostazol attenuates kainic acid-induced hippocampal cell death
Young-Seop Park, Zhen Jin, Eun Ae Jeong, Chin-ok Yi, Jong Youl Lee, In Sung Park, Gu Seob Roh
Korean J Physiol Pharmacol.2018;22(1):63-70.   Published online 2017 December 22     DOI: http://dx.doi.org/10.4196/kjpp.2018.22.1.63
      
8 Oral Administration of Cilostazol Increases Ocular Blood Flow in Patients with Diabetic Retinopathy
Duck Jin Hwang, Joo Young Shin, Hyeong Gon Yu
Korean J Ophthalmol.2017;31(2):123-131.   Published online 2017 March 21     DOI: http://dx.doi.org/10.3341/kjo.2017.31.2.123
      
9 Monitoring the Antiplatelet Effect of Cilostazol with Light Transmission Aggregometer: Two Cases of Possible Cilostazol Resistance
Hyoeun Shim, Seongsoo Jang, Chan-Jeoung Park, Hyun-Sook Chi, Seung-Whan Lee, Seong-Wook Park
Lab Med Online.2016;6(4):214-220.   Published online 2016 October 1     DOI: http://dx.doi.org/10.3343/lmo.2016.6.4.214
      
10 Successful sequential desensitization in a patient with drug hypersensitivity to three kinds of antiplatelet agents
Gun-Woo Kim, Sung-Yoon Kang, Kyoung-Hee Sohn, Sae-Hoon Kim, Sang-Heon Cho, Kyung-Up Min, Yoon-Seok Chang
Allergy Asthma Respir Dis.2016;4(5):374-377.   Published online 2016 September 30     DOI: http://dx.doi.org/10.4168/aard.2016.4.5.374
      
11 Pharmacokinetic characteristics of cilostazol 200 mg controlled-release tablet compared with two cilostazol 100 mg immediate-release tablets (Pletal) after single oral dose in healthy Korean male volunteers
Jin Dong Son, Sang Min Cho, Youn Woong Choi, Soo-Hwan Kim, In Sun Kwon, Eun-Heui Jin, Jae Woo Kim, Jang Hee Hong
Transl Clin Pharmacol.2016;24(4):183-188.   Published online 2016 January 19     DOI: http://dx.doi.org/10.12793/tcp.2016.24.4.183
   
12 Adjunctive Cilostazol versus High Maintenance Dose of Clopidogrel in Patients with Hyporesponsiveness to Chronic Clopidogrel Therapy
Ga Yeon Lee, Joo-Yong Hahn, Soo-Youn Lee, Hee-Jin Kim, Jun Hyung Kim, Sang-Yup Lee, Young Bin Song, Seung-Hyuk Choi, Jin-Ho Choi, Hyeon-Cheol Gwon
Yonsei Med J.2013;54(1):34-40.   Published online 2012 November 28     DOI: http://dx.doi.org/10.3349/ymj.2013.54.1.34
      
13 Cilostazol Decreases Ethanol-Mediated TNFalpha Expression in RAW264.7 Murine Macrophage and in Liver from Binge Drinking Mice
Youn Ju Lee, Jong Ryeol Eun
Korean J Physiol Pharmacol.2012;16(2):131-138.   Published online 2012 April 24     DOI: http://dx.doi.org/10.4196/kjpp.2012.16.2.131
      
14 Endothelial Dysfunction in the Smokers Can Be Improved with Oral Cilostazol Treatment
Kyu Seop Kim, Hyung Seo Park, Il Soon Jung, Jae-Hyeong Park, Kye Taek Ahn, Seon-Ah Jin, Yong Kyu Park, Jun Hyung Kim, Jae-Hwan Lee, Si Wan Choi, Jin-Ok Jeong, In-Whan Seong
J Cardiovasc Ultrasound.2011;19(1):21-25.   Published online 2011 March 31     DOI: http://dx.doi.org/10.4250/jcu.2011.19.1.21
      
15 Cilostazol Inhibits Vascular Smooth Muscle Cell Proliferation and Reactive Oxygen Species Production through Activation of AMP-activated Protein Kinase Induced by Heme Oxygenase-1
Jung Eun Kim, Jin Young Sung, Chang-Hoon Woo, Young Jin Kang, Kwang Youn Lee, Hee Sun Kim, Woo Hyung Kwun, Hyoung Chul Choi
Korean J Physiol Pharmacol.2011;15(4):203-210.   Published online 2011 February 18     DOI: http://dx.doi.org/10.4196/kjpp.2011.15.4.203
   
16 The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
Doo-Soo Jeon, Ki-Dong Yoo, Chan-Suk Park, Dong-Il Shin, Sung-Ho Her, Hoon-Joon Park, Yoon-Seok Choi, Dong-Bin Kim, Chong-Min Lee, Chul-Soo Park, Pum-Joon Kim, Keon-Woong Moon, Ki-Yuk Jang, Hee-Yeol Kim, Wook-Sung Chung, Ki-Bae Seung, Jae-Hyung Kim, Kyu-Bo Choi
Korean Circ J.2010;40(1):10-15.   Published online 2010 January 27     DOI: http://dx.doi.org/10.4070/kcj.2010.40.1.10
      
17 Cilostazol Attenuates 4-hydroxynonenal-enhanced CD36 Expression on Murine Macrophages via Inhibition of NADPH Oxidase-derived Reactive Oxygen Species Production
Mi Ran Yun, Hye Mi Park, Kyo Won Seo, Chae Eun Kim, Jung Wook Yoon, Chi Dae Kim
Korean J Physiol Pharmacol.2009;13(2):99-106.   Published online 2009 April 17     DOI: http://dx.doi.org/10.4196/kjpp.2009.13.2.99
   
18 Clinical Effects of Additional Cilostazol Administration After Drug-Eluting Stent Insertion
Dong Sung Kum, Moo Hyun Kim, Jeung Hoan Paik, Long Hao Yu, Jin Han, Kyung Ho Kim, Tae Ho Park, Kwang Soo Cha, Young Dae Kim, Mei Lian Quan, Jin Yeong Han
Korean Circ J.2009;39(1):21-25.   Published online 2009 January 31     DOI: http://dx.doi.org/10.4070/kcj.2009.39.1.21
      
19 Cilostazol Reduces PAC-1 Expression on Platelets in Ischemic Stroke
Su-Yun Lee, Myong-Jin Kang, Jae-Kwan Cha
J Clin Neurol.2008;4(4):148-152.   Published online 2008 December 31     DOI: http://dx.doi.org/10.3988/jcn.2008.4.4.148
      
20 The Clinical Effects of Cilostazol on Atherosclerotic Vascular Disease
Jong-Seon Park, Young-Jo Kim
Korean Circ J.2008;38(9):441-445.   Published online 2008 September 30     DOI: http://dx.doi.org/10.4070/kcj.2008.38.9.441
      

 1 of 2